-

10:07:31 AM

SCTL Stock News

SCTL - Societal CDMO Inc

08/16/22 7:00 AM

Nasdaq : SCTL

Societal CDMO Announces Signing of More Than $9 Million Sales and Purchase Agreement With David Weekley Homes for Excess Lakefront Land

Established Homebuilder to Purchase Approximately 121 Acres in Gainesville, Georgia, for Residential Development Proceeds from Sale to Strengthen Societal CDMO’s Corporate Balance Sheet Through Planned Debt Reduction; Second Real Estate Transaction in Process to Further Enhance Financial Position

RHEA-AI

neutral

08/10/22 4:05 PM

Nasdaq : SCTL

earnings

Societal CDMO Reports Second Quarter 2022 Financial Results

Recorded Q2 Revenue of $23.2 Million, a 29% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Clinical Trial Support, Commercial Manufacturing and Packaging Launched Innovative “20/80 Second Source Technical Transfer” Program; New Model Offers Increased

RHEA-AI

neutral

08/04/22 7:00 AM

Nasdaq : SCTL

clinical trial

Societal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic Candidates

RHEA-AI

neutral

08/03/22 4:05 PM

Nasdaq : SCTL

conferencesearnings

Societal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022

Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving

RHEA-AI

neutral

07/20/22 7:00 AM

Nasdaq : SCTL

clinical trial

Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe

Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO)

RHEA-AI

neutral

07/12/22 7:00 AM

Nasdaq : SCTL

Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products

Societal CDMO, Inc. (“Societal CDMO”; NASD:

RHEA-AI

positive

07/07/22 4:05 PM

Nasdaq : SCTL

Societal CDMO Reports Inducement Grants for New Staff

Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic

RHEA-AI

very positive

06/08/22 7:00 AM

Nasdaq : SCTL

Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish and Lyophilization Unit at San Diego Facility

Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a

RHEA-AI

neutral

06/01/22 7:00 AM

Nasdaq : SCTL

clinical trial

Societal CDMO Selected By AmyriAD Pharma to Provide Clinical Trials Services to Support Pivotal Phase 3 Program For Alzheimer’s Disease Treatment, AD101

Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO)

RHEA-AI

positive

05/19/22 7:00 AM

Nasdaq : SCTL

conferences

Societal to Participate in Upcoming Investor Conferences

Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule

RHEA-AI

neutral